If you would like to receive more information on organising a Corporate Satellite at ESHG 2021 – Virtual, please contact: Ms. Jantie de Roos at Rose INTERNATIONAL.
Please find below an overview of the Corporate Satellites during ESHG 2021 – Virtual. You will first find the LIVE Sessions followed by the On-demand Sessions.
Live Sessions
Saturday, August 28, 2021 – 13.45 – 14.45 hrs
Accelerating NGS analysis: automating best clinical practice to provide better outcomes for rare disease patients
Saturday, August 28, 13.45- 14.45 hrs
CS004
eVai – ACMG/ClinGen variant interpretation for mendelian diseases and beyond
Saturday, August 28, 13.45- 14.15 hrs
CS001
BRIDGES: Breast Cancer Risk After Diagnostic Gene Sequencing
Saturday, August 28, 13.45- 14.15 hrs
CS003
Long-read whole genome analysis of human single cells
Saturday, August 28, 13.45- 14.15 hrs
CS005
Saturday, August 28, 2021 – 20.00 – 21.30 hrs
Advances in Synthetic Oligo Synthesis to Revamp Your Workflow
Saturday, August 28, 20.00 – 21.00 hrs
CS008
Sunday, August 29, 2021 – 14.00 – 15.00 hrs
Introducing the SEQ Platform: What it brings to the genetic diagnostics field with extended annotation, VUS+ and VUS++ classifications, and genotype/phenotype database features
Sunday, August 29, 14.00 – 14.30 hrs
CS018
VSClinical: A Comprehensive NGS Clinical Solution
Sunday, August 29, 14.00 – 15.00 hrs
CS016
Increasing Solve Rates in Rare and Mendelian Disease Research with Long-Read Sequencing
Sunday, August 29, 14.00 – 14.30 hrs
CS015
Single cell sequencing: a new dimension in cancer diagnosis and treatment
Sunday, August 29, 14.00 – 15.00 hrs
CS017
Automated. Validated. Compliant. Navigate the NGS universe with confidence
Sunday, August 29, 14.00 – 15.00 hrs
CS014
Sunday, August 29, 2021 – 17.30 – 18.00 hrs
New frontiers in NIPT – Artificial Intelligence and the SMART approach to testing
Sunday, August 29, 17.30 – 18.00 hrs
CS019
Monday, August 30, 2021 – 12.00 – 13.00 hrs
Part I: Bringing Clinical Value Through Enhanced Panel-based Testing & mtDNA analysis.
Part II: Solving Diagnostic Challenges in Difficult-to-Sequence Regions
Monday, August 30, 12.00 – 13.00 hrs
CS033
A journey of spatial multi-omics in oncology, neuroscience and fibrosis: from areas of interest to data analysis.
Monday, August 30, 12.00 – 13.00 hrs
CS035
A non-PCR and Targeted cfDNA Testing in Clinical Practice
Monday, August 30, 12.00 – 12.30 hrs
CS031
Lead the frontline of clinical research with Whole Exome Sequencing
Monday, August 30, 12.00 – 13.00 hrs
CS034
Accurate Colorectal Neoplasia Detection Through Targeted Bisulfite Sequencing Analysis of Cell-free Circulating Tumor DNA (ctDNA)
Monday, August 30, 12.00 – 12.30 hrs
CS032
Monday, August 30, 2021 – 15.30 – 16.30 hrs
Next Gen Life Sciences Innovations
Monday, August 30, 15.30 – 16.30 hrs
CS039
Performance of Long-read sequencing in resolving human genetic language and BMKCloud based data mining
Monday, August 30, 15.30 – 16.00 hrs
CS056
Enlightening the dark matter of the genome: Optical Genome Mapping identifies germline retrotransposon insertion in SMARCB1 in two siblings with Atypical Teratoid Rhabdoid Tumor
Monday, August 30, 15.30 – 16.30 hrs
CS036
Time to change: Transitioning from arrays to NGS in CLL & ID/DD analysis with confidence
Monday, August 30, 15.30 – 16.30 hrs
CS037
Advancing human genetics research with nanopore sequencing
Monday, August 30, 15.30 – 16.30 hrs
CS040
microRNA profiling for biomarker development and molecular mechanism-of-action studies
Monday, August 30, 15.30 – 16.30 hrs
CS054
Focusing on what matters most: streamlined secondary and tertiary analyses for clinical exome sequencing
Monday, August 30, 15.30 – 16.30 hrs
CS038
Monday, August 30, 2021 – 18.45 – 19.45 hrs
Understanding physiologically relevant pathways using Abcam’s KO cell lines
Monday, August 30, 18.45 – 19.15 hrs
CS043
Hi-C technology and the role of enhancer rewiring in cancer
Monday, August 30, 18.45 – 19.15 hrs
CS042
Supporting the New ACMG Guidelines for NGS based CNVs for Genetic Testing Labs
Monday, August 30, 18.45 – 19.45 hrs
CS041
Performance of exome CNVs vs traditional methods in clinical environments
Monday, August 30, 18.45 – 19.45 hrs
CS055
Monday, August 30, 2021 – 20.15 – 21.45 hrs
Saliva RNA for the detection and management of concussion: Discovery, validation and commercialization
Monday, August 30, 20.15 – 20.45 hrs
CS049
Opportunities in Precision Oncology: Liquid Biopsy and Interpretation Software
Monday, August 30, 20.15 – 21.15 hrs
CS044
Tuesday, August 31, 2021 – 14.15 – 15.15 hrs
Single Cell Multiomics and Spatially Resolved Transcriptomics – Towards a deeper understanding of disease pathogenesis
Tuesday, August 31, 14.15 – 14.45 hrs
CS053
Optimising germline BRCA testing and beyond
Tuesday, August 31, 14.15 – 15.15 hrs
CS052
Looking Beyond Copy Number – Using AmplideX® Technology to Support SMA Diagnosis, Screening, and Research
Tuesday, August 31, 14.15 – 15.15 hrs
CS050
Detection and monitoring of mutations from liquid biopsy – a clinical study
Tuesday, August 31, 14.15 – 15.15 hrs
CS051
Tuesday, August 31, 2021 – 18.30 – 20.00 hrs
On-demand Sessions
Low-Pass Whole Genome Sequencing: a new standard for genome wide association studies at the cost of genotyping arrays
CS064
Rapidly identify pathogenic structural variants (SVs) in whole genome sequence data from 50+ rare disease cases using Fabric’s AI Software
CS007
Clinical Perspectives: Optimized Variant Interpretation with the Mastermind Genomic Search Engine
CS072
Design and optimization of a new NGS sequencing panel for detecting somatic mutations in hematological malignancies
CS076
A new era in infection and immunity research –
From immune sequencing to host response to Covid-19 and mRNA vaccine development
CS080
